Tepotinib (EMD-1214063) is an orally active, highly selective, reversible, ATP-competitive c-Met inhibitor. It is >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Tepotinib inhibits c-Met phosphorylation, induces autophagy, and exhibits antitumor effects.
- Highly selective c-Met inhibitor
- Orally active
- Reversible and ATP-competitive
- Inhibits c-Met phosphorylation
- Induces autophagy
- Exhibits antitumor effects